SCHEMBL5511341

SCHEMBL5511341

Cc1ccc(S(=O)(=O)NN(CCCC2(O)CCCCC2)C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
ALDH1A1 P00352 7/20 0.38
CYP3A4 P08684 2/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
MAPT P10636 1/20 0.38
ALOX12 P18054 1/20 0.38
NFKB1 P19838 1/20 0.38
KMT2A Q03164 3/20 0.37
CA2 P00918 2/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ALOX15 P16050 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1863099 0.85 F2 (0.37) POLBALDH1A1CYP3A4GAAKDM4E
SCHEMBL5508653 0.76 ALDH1A1 (0.47) POLBALDH1A1GAAMAPTKMT2A
SCHEMBL17205742 0.74 ALDH1A1 (0.51) ALDH1A1CYP3A4KMT2ACA2CA12
SCHEMBL5509407 0.73 CYP2C19 (0.32)
SCHEMBL17205595 0.72 ALDH1A1 (0.53) ALDH1A1CYP3A4GAAKMT2ACA2
SCHEMBL17206111 0.71 ALDH1A1 (0.51) ALDH1A1CYP3A4KMT2ACA2CA12
SCHEMBL17206047 0.69 ALDH1A1 (0.53) ALDH1A1CYP3A4GAAKMT2ACA2
SCHEMBL3497447 0.69 SMN1; SMN2 (0.41) POLBALDH1A1CYP3A4GAAKDM4E
SCHEMBL9466282 0.67 KMT2A (0.45) ALDH1A1CYP3A4GAAKMT2ACA12
SCHEMBL1863742 0.67 TSHR (0.42) ALDH1A1CYP3A4KMT2ACA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed